CLINICAL TRIALS PROFILE FOR GALLIUM GA-68 PSMA-11
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
All Clinical Trials for Gallium Ga-68 Psma-11
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00002543 ↗ | Gallium Nitrate in Treating Children With Brain Tumor, Neuroblastoma, Rhabdomyosarcoma, Non-Hodgkin's Lymphoma, or Refractory Solid Tumors | Completed | National Cancer Institute (NCI) | Phase 1 | 1995-02-01 | RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: : Phase I trial to study the effectiveness of gallium nitrate in young patients who have malignant brain tumors, neuroblastoma, rhabdomyosarcoma, non-Hodgkin's lymphoma, or refractory solid tumor. |
| NCT00002543 ↗ | Gallium Nitrate in Treating Children With Brain Tumor, Neuroblastoma, Rhabdomyosarcoma, Non-Hodgkin's Lymphoma, or Refractory Solid Tumors | Completed | Medical College of Wisconsin | Phase 1 | 1995-02-01 | RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: : Phase I trial to study the effectiveness of gallium nitrate in young patients who have malignant brain tumors, neuroblastoma, rhabdomyosarcoma, non-Hodgkin's lymphoma, or refractory solid tumor. |
| NCT00002578 ↗ | Gallium Nitrate in Treating Patients With AIDS-Related Non-Hodgkin's Lymphoma | Completed | National Cancer Institute (NCI) | Phase 2 | 1994-08-01 | RATIONALE: Chemotherapy uses different ways to stop cancer cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of gallium nitrate in treating patients with AIDS-related non-Hodgkin's lymphoma. |
| NCT00002578 ↗ | Gallium Nitrate in Treating Patients With AIDS-Related Non-Hodgkin's Lymphoma | Completed | Roswell Park Cancer Institute | Phase 2 | 1994-08-01 | RATIONALE: Chemotherapy uses different ways to stop cancer cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of gallium nitrate in treating patients with AIDS-related non-Hodgkin's lymphoma. |
| NCT00004010 ↗ | Combination Chemotherapy and Radiation Therapy in Treating Children With Previously Untreated Stage II, Stage III, or Stage IV Hodgkin's Disease | Completed | National Cancer Institute (NCI) | Phase 2 | 1999-10-01 | RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more cancer cells. Radiation therapy uses high-energy x-rays to damage cancer cells. Giving radiation therapy after chemotherapy may be an effective treatment for Hodgkin's disease. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy and radiation therapy in treating children who have previously untreated stage II, stage III, or stage IV Hodgkin's disease. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Gallium Ga-68 Psma-11
Condition Name
Clinical Trial Locations for Gallium Ga-68 Psma-11
Trials by Country
Clinical Trial Progress for Gallium Ga-68 Psma-11
Clinical Trial Phase
Clinical Trial Sponsors for Gallium Ga-68 Psma-11
Sponsor Name
